Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « major »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
maintenance < major < majority  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 42.
[0-20] [0 - 20][0 - 42][20-40]
Ident.Authors (with country if any)Title
000039 (2011) Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
000173 (2013) Nam Trung Nguyen [Japon, Viêt Nam] ; Taisuke Nakahama [Japon] ; Tadamitsu Kishimoto [Japon]Aryl hydrocarbon receptor and experimental autoimmune arthritis
000204 (2010) C. J. Edwards [Royaume-Uni] ; E. Williams [Royaume-Uni]The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis
000212 (2013) Pierre GangloffBiothérapie et odontologie
000214 (2012) Fatma Alibaz-Oner [Turquie] ; Sibel Zehra Aydin [Turquie] ; Haner Direskeneli [Turquie]Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis
000222 (2008) M. Aringer [Allemagne] ; E. Feierl [Autriche] ; J. Smolen [Autriche]Zytokinblockade – eine vielversprechende Therapieoption bei SLE
000246 (2011) Bernard Bannwarth [France]Prise en charge thérapeutique de l’inflammation d’origine rhumatismale
000251 (2006) Chi Chiu Mok [Hong Kong]Biological therapies for rheumatoid arthritis: beyond TNF‐α blockade
000303 (2013) Verena Wieser [Autriche] ; Alexander R. Moschen [Autriche] ; Herbert Tilg [Autriche]Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective
000314 (2010) Ukihide Tateishi [Japon] ; Tomoyuki Imagawa [Japon] ; Noriko Kanezawa [Japon] ; Tetsuhiko Okabe [Japon] ; Kazuya Shizukuishi [Japon] ; Tomio Inoue [Japon] ; Shumpei Yokota [Japon]PET assessment of disease activity in children with juvenile idiopathic arthritis
000530 (2011) Dimitrios Christidis [Royaume-Uni] ; Shaifali Jain [Royaume-Uni] ; Bhaskar Das Gupta [Royaume-Uni]Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvement
000536 (2009) Katalin Eder [Hongrie] ; Noemi Baffy [Hongrie] ; Andras Falus [Hongrie] ; Andras K. Fulop [Hongrie]The major inflammatory mediator interleukin-6 and obesity
000862 (2011) Shunichi Shiozawa [Japon] ; Ken Tsumiyama [Japon] ; Kohsuke Yoshida [Japon] ; Akira Hashiramoto [Japon]Pathogenesis of Joint Destruction in Rheumatoid Arthritis
000956 (2009) Larry W. Moreland [États-Unis]Cytokines as Targets for Anti‐inflammatory Agents
000A49 (2009) Khader N. Mustafa [Jordanie] ; Azmy Hadidy [Jordanie] ; Nadera J. Sweiss [États-Unis]Clinical and radiological features of Takayasu’s arteritis patients in Jordan
000B27 (2012) Jae Kuk Ryu [Corée du Sud] ; Hyo Sun Kim [Corée du Sud] ; Doo Hyun Nam [Corée du Sud]Current status and perspectives of biopharmaceutical drugs
000B29 (2010) W. Fiori [Allemagne] ; A. Liedtke-Dyong [Allemagne] ; H.-J. Lakomek [Allemagne] ; K. Buscham [Allemagne] ; H. Lehmann [Allemagne] ; W. Liman [Allemagne] ; A.-K. Fuchs [Allemagne] ; F. Bessler [Allemagne] ; N. Roeder [Allemagne]Das G-DRG-System 2010 – Relevantes für die Rheumatologie
000B45 (2011) Naoya Mikita [Japon] ; Takaharu Ikeda ; Mariko Ishiguro ; Fukumi FurukawaRecent advances in cytokines in cutaneous and systemic lupus erythematosus
000B67 (2012) Sandeep Kumar [États-Unis] ; Mark A. Mitchell [États-Unis] ; Bonita Rup [États-Unis] ; Satish K. Singh [États-Unis]Relationship between potential aggregation‐prone regions and HLA‐DR‐binding T‐cell immune epitopes: Implications for rational design of novel and follow‐on therapeutic antibodies
000B79 (2013) G. J. Carroll ; K. Makin ; B. Carroll ; S. Curtin ; M. Bulsara [Australie]FRI0131 Mannose binding lectin (MBL) deficiency is a major risk factor for multiple serious infections (SI) in rheumatoid arthritis
000C40 (2013) J. Braun [Allemagne]SP0060 Spondyloarthritis/ankylosing spondylitis drug therapy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "major" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "major" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    major
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021